Suppr超能文献

创新技术在个性化癌症医学中的应用:干细胞与基因编辑工具

Applications of Innovation Technologies for Personalized Cancer Medicine: Stem Cells and Gene-Editing Tools.

作者信息

Hasanzadeh Akbar, Ebadati Arefeh, Dastanpour Lida, Aref Amir R, Sahandi Zangabad Parham, Kalbasi Alireza, Dai Xiaofeng, Mehta Geeta, Ghasemi Amir, Fatahi Yousef, Joshi Suhasini, Hamblin Michael R, Karimi Mahdi

机构信息

Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran 14535, Iran.

Department of Medical Nanotechnology, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran 14535, Iran.

出版信息

ACS Pharmacol Transl Sci. 2023 Nov 14;6(12):1758-1779. doi: 10.1021/acsptsci.3c00102. eCollection 2023 Dec 8.

Abstract

Personalized medicine is a new approach toward safer and even cheaper treatments with minimal side effects and toxicity. Planning a therapy based on individual properties causes an effective result in a patient's treatment, especially in a complex disease such as cancer. The benefits of personalized medicine include not only early diagnosis with high accuracy but also a more appropriate and effective therapeutic approach based on the unique clinical, genetic, and epigenetic features and biomarker profiles of a specific patient's disease. In order to achieve personalized cancer therapy, understanding cancer biology plays an important role. One of the crucial applications of personalized medicine that has gained consideration more recently due to its capability in developing disease therapy is related to the field of stem cells. We review various applications of pluripotent, somatic, and cancer stem cells in personalized medicine, including targeted cancer therapy, cancer modeling, diagnostics, and drug screening. CRISPR-Cas gene-editing technology is then discussed as a state-of-the-art biotechnological advance with substantial impacts on medical and therapeutic applications. As part of this section, the role of CRISPR-Cas genome editing in recent cancer studies is reviewed as a further example of personalized medicine application.

摘要

个性化医疗是一种新的方法,旨在实现更安全、甚至更便宜的治疗,同时使副作用和毒性降至最低。根据个体特征规划治疗方案能在患者治疗中产生有效结果,尤其是在癌症等复杂疾病的治疗中。个性化医疗的益处不仅包括高精度的早期诊断,还包括基于特定患者疾病独特的临床、遗传和表观遗传特征以及生物标志物谱制定更合适、有效的治疗方法。为了实现个性化癌症治疗,了解癌症生物学起着重要作用。由于其在开发疾病治疗方面的能力,个性化医疗最近受到更多关注的关键应用之一与干细胞领域有关。我们综述了多能干细胞、成体干细胞和癌症干细胞在个性化医疗中的各种应用,包括靶向癌症治疗、癌症建模、诊断和药物筛选。接着讨论了CRISPR-Cas基因编辑技术,它是一项具有重大医学和治疗应用影响的前沿生物技术进展。作为本节的一部分,回顾了CRISPR-Cas基因组编辑在近期癌症研究中的作用,作为个性化医疗应用的进一步示例。

相似文献

1
Applications of Innovation Technologies for Personalized Cancer Medicine: Stem Cells and Gene-Editing Tools.
ACS Pharmacol Transl Sci. 2023 Nov 14;6(12):1758-1779. doi: 10.1021/acsptsci.3c00102. eCollection 2023 Dec 8.
2
Integrating Prime Editing and Cellular Reprogramming as Novel Strategies for Genetic Cardiac Disease Modeling and Treatment.
Curr Cardiol Rep. 2024 Nov;26(11):1197-1208. doi: 10.1007/s11886-024-02118-2. Epub 2024 Sep 11.
3
Use of genome editing tools in human stem cell-based disease modeling and precision medicine.
Yi Chuan. 2015 Oct;37(10):983-91. doi: 10.16288/j.yczz.15-239.
4
Current progress in CRISPR-Cas systems for autoimmune diseases.
Prog Mol Biol Transl Sci. 2024;208:231-259. doi: 10.1016/bs.pmbts.2024.07.011. Epub 2024 Aug 14.
5
A review on CRISPR/Cas: a versatile tool for cancer screening, diagnosis, and clinic treatment.
Funct Integr Genomics. 2023 May 26;23(2):182. doi: 10.1007/s10142-023-01117-w.
6
Revolutionizing therapy with CRISPR/Cas genome editing: breakthroughs, opportunities and challenges.
Front Genome Ed. 2024 Feb 1;6:1342193. doi: 10.3389/fgeed.2024.1342193. eCollection 2024.
8
Organoid factory: The recent role of the human induced pluripotent stem cells (hiPSCs) in precision medicine.
Front Cell Dev Biol. 2023 Jan 9;10:1059579. doi: 10.3389/fcell.2022.1059579. eCollection 2022.
9
CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review.
Protein Pept Lett. 2020;27(10):931-944. doi: 10.2174/0929866527666200407112432.
10
Application of CRISPR-Cas9 gene editing technology in basic research, diagnosis and treatment of colon cancer.
Front Endocrinol (Lausanne). 2023 Mar 20;14:1148412. doi: 10.3389/fendo.2023.1148412. eCollection 2023.

本文引用的文献

1
Current advances in prognostic and diagnostic biomarkers for solid cancers: Detection techniques and future challenges.
Biomed Pharmacother. 2022 Feb;146:112488. doi: 10.1016/j.biopha.2021.112488. Epub 2021 Dec 9.
2
Nanotechnology-based delivery of CRISPR/Cas9 for cancer treatment.
Adv Drug Deliv Rev. 2021 Sep;176:113891. doi: 10.1016/j.addr.2021.113891. Epub 2021 Jul 26.
3
Immunogenomics in personalized cancer treatments.
J Hum Genet. 2021 Sep;66(9):901-907. doi: 10.1038/s10038-021-00950-w. Epub 2021 Jun 30.
4
Exploring liver cancer biology through functional genetic screens.
Nat Rev Gastroenterol Hepatol. 2021 Oct;18(10):690-704. doi: 10.1038/s41575-021-00465-x. Epub 2021 Jun 23.
5
Molecular subtypes of colorectal cancer: An emerging therapeutic opportunity for personalized medicine.
Genes Dis. 2019 Oct 30;8(2):133-145. doi: 10.1016/j.gendis.2019.10.013. eCollection 2021 Mar.
6
Patient-derived organoids as a predictive biomarker for treatment response in cancer patients.
NPJ Precis Oncol. 2021 Apr 12;5(1):30. doi: 10.1038/s41698-021-00168-1.
7
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
8
Multiplex bioimaging of single-cell spatial profiles for precision cancer diagnostics and therapeutics.
NPJ Precis Oncol. 2020 May 1;4:11. doi: 10.1038/s41698-020-0114-1. eCollection 2020.
9
Application of CRISPR/Cas9 gene editing technique in the study of cancer treatment.
Clin Genet. 2020 Jan;97(1):73-88. doi: 10.1111/cge.13589. Epub 2019 Jul 10.
10
The Pros and Cons of Mesenchymal Stem Cell-Based Therapies.
Cell Transplant. 2019 Jul;28(7):801-812. doi: 10.1177/0963689719837897. Epub 2019 Apr 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验